GPT and hepatocellular carcinoma: In particular, AST levels were higher also in the NO HCC-APRI ≥0.5 group, whereas the more liver-specific markers ALT and GGT were significantly higher in the HCC-APRI ≥0.5 group, even when compared to the NO HCC-APRI ≥0.5 group.